Skip to main content
SpringerLink
Log in

Little concordance in CE evaluations between USA and UK

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. National Health Service

Reference

  • Cherla A, et al. Cost-Effectiveness of Cardiovascular, Obesity, and Diabetes Mellitus Drugs: Comparative Analysis of the United States and England. Journal of the American Heart Association 9: No. 21, 30 Oct 2020. Available from: URL: https://doi.org/10.1161/JAHA.120.018281

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Little concordance in CE evaluations between USA and UK. PharmacoEcon Outcomes News 866, 23 (2020). https://doi.org/10.1007/s40274-020-7283-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7283-6

Search

Navigation